Deoxyglucose: Clinical Trials

6 trials of Deoxyglucose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 withdrawn. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Terminated 1, Withdrawn 1
Phase 23Terminated 2, Completed 1

Follow Deoxyglucose: new trials by email Literature Review of Deoxyglucose trials Research Report on Deoxyglucose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults
2-Deoxy-D-glucose, Placebo - Acute Nasopharyngitis
Phase 2TerminatedG.ST Antivirals GmbH642024-04-022024-11-19
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
Oral 2-Deoxy-D-Glucose (2DG) - Epilepsy; Seizure
Phase 2CompletedUniversity of Virginia92022-09-022026-06-09
Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers
2-Deoxyglucose, Placebo - Acute Nasopharyngitis
Phase 1CompletedG.ST Antivirals GmbH452022-03-032023-10-12
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
2-deoxyglucose - Prostate Cancer
Phase 1 / Phase 2TerminatedRutgers, The State University of New Jersey122006-11-012023-12-22
Safety Study of 2DG With Stereotactic Radiosurgery
2-deoxyglucose (2DG) - Intracranial Neoplasms, Neoplasm Metastasis
Phase 1WithdrawnUniversity of Iowa2005-10-012015-04-10
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
2-deoxy-D-glucose (2DG) - Lung Cancer, Breast Cancer
Phase 1CompletedThreshold Pharmaceuticals502004-02-012009-04-29

Conditions studied

Common Cold (2)  ·  Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Epilepsy (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Respiratory Tract Infections (1)  ·  Stomach Neoplasms (1)  ·  Virus Diseases (1)

Sponsors

G.ST Antivirals GmbH (2)  ·  Rutgers, The State University of New Jersey (1)  ·  Threshold Pharmaceuticals (1)  ·  University of Iowa (1)  ·  University of Virginia (1)

Countries

United States (4)  ·  Austria (1)  ·  Netherlands (1)

Top investigators

Ingrid de Visser-Kamerling, PhD (1)  ·  John M. Buatti, M.D. (1)  ·  Luis Raez, MD (1)  ·  Nathan B Fountain, MD (1)  ·  Robert DiPaola, MD (1)

Results publications

PMID 23228990, PMID 40101848